Organisation & Partners
Research and Clinical Studies
Patient & Public Involvement
Baseline neutrophil‐to‐lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis, AP&T. 2019.
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nature Communications. 2019.
Obesity in acute alcoholic hepatitis increases morbidity and mortality. EBioMedicine. 2019.
Systematic review with meta‐analysis: high mortality in patients with non‐severe alcoholic hepatitis. AP&T. 2019.
The future of therapy for alcoholic hepatitis – Beyond corticosteroids. Journal of Hepatology. 2019.
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. Hepatology. 2018.
Assessment and management of infection in alcoholic hepatitis. Seminars in Liver Disease. 2019.
Endpoints and patient stratification in clinical trials for alcoholic hepatitis. Journal of Hepatology. 2019.
Alcohol-related liver disease: areas of consensus, unmet needs and opportunities for further study. Journal of Hepatology. 2019.
Corticosteroids Reduce Risk of Death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials. Gastroenterology. 2018.
Liver transplantation for alcoholic hepatitis: being consistent about where to set the bar. Liver Transplantation. 2018.
Serum transferrin is an independent predictor of mortality in severe alcoholic hepatitis. The American Journal of Gastroenterology. 2020.
PS-174 Serum bile acid profiles distinguish severe alcoholic hepatitis from decompensated alcohol-related cirrhosis. 2019.